Vabicaserin is a novel antipsychotic and anorectic under development. References: Palacios JM, Pazos A, Hoyer D. A short history of the 5-HT(2C) receptor: from the choroid plexus to depression, obesity and addiction treatment. Psychopharmacology (Berl). 2017 May;234(9-10):1395-1418. doi: 10.1007/s00213-017-4545-5. Epub 2017 Mar 7. Review. PubMed PMID: 28265714.
纯度:≥98%
CAS:887258-95-9